Finding US recession sector opportunities in the S&P500
7 months ago at 17 Aug 2022
Illumina, Inc. is an American biotech company with its headquarters in San Diego, California.
IIllumina, as a health tech company, develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. On Tuesday, after the close, it will report its earnings.
Historically the stock tends to gain over this period of time with a 73%-win percentage between February 03 and February 15.
So, does this mean that Illumina will repeat its seasonal pattern again this year? Or will earnings disappoint and send the stock lower?
Major Trade Risks:
The major trade risk here is that the seasonal pattern does not repeat itself again this year.
Remember, don’t just trade it, but Seasonax it!